Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. NOW
4. TXN
5. GOOG
6. AMD
7. CSX
8. KNX
9. IBM
10. LVS

Go back to Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
Compugen Ltd (NASDAQ: CGEN) Delayed: 2.33 -0.09 (3.72%)
Previous Close $2.42    52 Week High $7.79 
Open $2.39    52 Week Low $4.32 
Day High $2.40    P/E N/A 
Day Low $2.33    EPS $-0.36 
Volume 138,414       

Compugen Ltd (NASDAQ: CGEN) Delayed: 2.33 -0.09 (3.72%)
Previous Close $2.42    52 Week High $7.79 
Open $2.39    52 Week Low $4.32 
Day High $2.40    P/E N/A 
Day Low $2.33    EPS $-0.36 
Volume 138,414